Infections of the Urinary Tract

  • Nina Tolkoff-Rubin
  • Robert H. Rubin


Urinary tract infections are the most common of all bacterial infections, accounting for more than 7 million physician visits each year, as well as resulting in over 1 million hospital admissions annually in the U.S. (1–3). In this era of managed care, an approach to the care of the patient with urinary tract infection not only requires a knowledge of the microbiology and pathogenesis of this disease entity but also needs to focus on the most cost-effective therapeutic strategies.


Urinary Tract Urinary Tract Infection Recurrent Urinary Tract Infection Acute Pyelonephritis Asymptomatic Bacteriuria 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Patton JP, Nash DB, Abrutyn E: Urinary tract infection: Economic considerations. Med Clin North Am 75: 495–513, 1991.PubMedGoogle Scholar
  2. 2.
    Haley RW, Culver DH, White JW, Morgan WM, Emori TG: The nationwide nosocomial infection rate: a new need for vital statistics. Am J Epidemiol 121: 159–167, 1985.PubMedGoogle Scholar
  3. 3.
    Stamm W, Hooton TM: Management of urinary tract infections in adults. N Engl J Med 239 (18): 1328–1333, 1994.Google Scholar
  4. 4.
    Sobel JD: Pathogenesis of urinary tract infections: Host defenses. Infect Dis Clin North Am 1: 751–772, 1987.PubMedGoogle Scholar
  5. 5.
    Barnes RC, Daifuko R, Roddy RE, Stamm WE: Urinary tract infection in sexually active homosexual men. Lancet 1: 171, 1986.PubMedCrossRefGoogle Scholar
  6. 6.
    Spach DH, Stapleton AE, Stamm WE: Lack of circumcision increases the risk of urinary tract infection in young men. JAMA 267: 679–681, 1992.PubMedCrossRefGoogle Scholar
  7. 7.
    Lipsky BA: Urinary tract infections in men: epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med 110: 138–143, 1989.PubMedCrossRefGoogle Scholar
  8. 8.
    Raz R, Stamm WE: A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 329: 753–756, 1992.CrossRefGoogle Scholar
  9. 9.
    Hooton TM, Fennell CL, Clark AM, Stamm WE: Nonoxynol9: Differential antibacterial activity and enhancement of bacterial adherence to vaginal endothelial cells. J Infect Dis 164: 1216–1219, 1991.PubMedCrossRefGoogle Scholar
  10. 10.
    Strom BL, Collins M, West SL, Kreisberg J, Weller S: Sexual activity, contraceptive use, and other risk factors for symptomatic and asymptomatic bacteriuria: a case control study. Ann Intern Med 107: 817–823, 1987.CrossRefGoogle Scholar
  11. 11.
    Arthur M, Johnson CE, Rubin RH, Arbeit RD, Campanelli C, Kim C, Steinback S, Agarwal M, Wilkinson R, Goldstein R: Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic E. coli. Infect Immunol 57: 303308, 1989.Google Scholar
  12. 12.
    Schaeffer AJ, Jones JM, Dunn JK: Association of in vitro E. coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary tract infections. N Engl.1 Med 304: 1062–1066, 1981.CrossRefGoogle Scholar
  13. 13.
    Stapleton A, Nudelman E, Clausen H, Hakomori S, Stamm WE: Binding of uropathogenic E. coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo blood group secretor status. J Clin Invest 90: 965–972, 1992.PubMedCrossRefGoogle Scholar
  14. 14.
    Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, Rogatko A, Fair WR: Association of the Lewis blood group phenotype with recurrent urinary tract infections in women. N Engl J Med 320: 773–777, 1989.PubMedCrossRefGoogle Scholar
  15. 15.
    Svanborg-Eden C, Hausson S, Jodal U: Host parasite interaction in the urinary tract. J Infect Dis 157: 421–426, 1988.PubMedCrossRefGoogle Scholar
  16. 16.
    Svanborg C: Resistance to urinary tract infection. N Engl J Med 329: 802–803, 1993.PubMedCrossRefGoogle Scholar
  17. 17.
    Svanborg C, deMain P, Sandberg T: Renal involvement in urinary tract infection. Kidney Int 39: 541–546, 1991.PubMedCrossRefGoogle Scholar
  18. 18.
    Johnson JR, Stamm WE: Urinary tract infections in women: diagnosis and treatment. Ann Intern Med 111: 906–917, 1989.PubMedCrossRefGoogle Scholar
  19. 19.
    Ronald AR, Boutros P, Mourtada H: Bacteriuria localization and response to single-dose therapy in women. JAMA 235: 1954–1856, 1976.CrossRefGoogle Scholar
  20. 20.
    Hooten TM, Stamm WE: Management of acute uncomplicated urinary tract infections in adults. Med Clin North Am 75: 339–357, 1991.Google Scholar
  21. 21.
    Rubin RH, Shapiro ED, Androle VT, Davis RJ, Stamm WE: Evaluation of new anti-infective drugs for the treatment of urinary tract infections. Clin Infect Dis 15 (Suppl 1): S216 - S227, 1992.PubMedCrossRefGoogle Scholar
  22. 22.
    Pappas PG: Laboratory in the diagnosis and management of urinary tract infections. Med Clin North Am 75: 313–325, 1991.Google Scholar
  23. 23.
    Inter-Nordic Urinary Tract Infection Study Group: Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections. Scand J Infect Dis 20: 619–624, 1988.CrossRefGoogle Scholar
  24. 24.
    Norby SR: Short term treatment of uncomplicated lower urinary tract infection in women. Rev Infect Dis 12: 458–467, 1990.CrossRefGoogle Scholar
  25. 25.
    Hooten TM, Johnson C, Winter C, et al.: Single dose and three day regimens of ofloxacin vs. trimethoprim-sulfamethoxazole for acute cystitis in women. Antimicrob Agents Chemother (35): 1479–1483, 1991.Google Scholar
  26. 26.
    Ronald AR, Nicolle LE, Harding GK: Standards of therapy for urinary tract infections in adults. Infection 20 (Suppl 3): S164 - S170, 1992.PubMedCrossRefGoogle Scholar
  27. 27.
    Nicolle LE, Ronald AR: Recurrent urinary tract infection in adult women: diagnosis and treatment. Infect Dis Clin North Am 1: 793–806, 1987.Google Scholar
  28. 28.
    Fowler JE, Pulaski ET: Excretory urography, cystography, and cystoscopy in the evaluation of women with urinary tract infection: a prospective study. N Engl J Med 304: 462–465, 1981.PubMedCrossRefGoogle Scholar
  29. 29.
    Ronald AR, Pattullo AL: The natural history of urinary tract infections in adults. Med Clin North Am 75: 299–312, 1991.PubMedGoogle Scholar
  30. 30.
    Hooton TM, Hillier S, Johnson C, Roberts PL, Stamm WE: E. coli bacteriuria and contraceptive method. JAMA 265: 64–69, 1991.PubMedCrossRefGoogle Scholar
  31. 31.
    Harding GKM, Ronald AR, Nicolle LE, et al.: Long term antimicrobial prophylaxis for recurrent urinary tract infections in women. Rev Infect Dis 4: 438–443, 1982.PubMedCrossRefGoogle Scholar
  32. 32.
    Stapleton A, Latham RH, Johnson C, Stam WE: Postcoital antimicrobial prophylaxis for recurrent urinary tract infection: a randomized, double-blind, placebo-controlled trial. JAMA 264: 703–706, 1990.PubMedCrossRefGoogle Scholar
  33. 33.
    Avorn J, Monane M, Gurwitz JH, et al.: Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 271: 751, 1992.CrossRefGoogle Scholar
  34. 34.
    Otto G, Sandberg T, Marklung BI, Vileryd P, Svanborg C: Virulence factors and pap genotype in E. coli isolates from women with acute pyelonephritis with and without bacteremia. Clin Infect Dis 17: 448–456, 1993.PubMedCrossRefGoogle Scholar
  35. 35.
    Lombert H, deMan P, Svanborg-Eden C: Bacterial and host determinants of renal scarring. APMIS 97: 193–197, 1989.CrossRefGoogle Scholar
  36. 36.
    Svanborg C: E. coli in patients with renal scarring: genotype and phenotype of gal alpha 1–4 gal beta Forssman-and manose-specific adhesins. Pediatr Infect Dis 10: 15–18, 1991.Google Scholar
  37. 37.
    Abrutyn E, Mossey J, Berlin J, et al.: Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women? Ann Intern Med 120: 827–833, 1994.PubMedCrossRefGoogle Scholar
  38. 38.
    Andriole VT, Patterson TF: Epidemiology, natural history, and management of urinary tract infections in pregnancy. Med Clin North Am 75: 359–373, 1991.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Nina Tolkoff-Rubin
    • 1
  • Robert H. Rubin
    • 2
  1. 1.End-Stage Renal Disease Program, Hemodialysis and CAPD UnitsMassachusetts General Hospital Harvard Medical SchoolBostonUSA
  2. 2.Center for Experimental Pharmacology and Therapeutics, Harvard-M.I.T. Division of Health Sciences and Technology, Transplantation Infectious DiseaseMassachusetts General Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations